Search…

    Saved articles

    You have not yet added any article to your bookmarks!

    Browse articles
    Select News Languages

    GDPR Compliance

    We use cookies to ensure you get the best experience on our website. By continuing to use our site, you accept our use of cookies, Privacy Policies, and Terms of Service.

    Friedreich's Ataxia Patients Celebrate Drug Approval

    3 weeks ago

    15

    0

    Patients with Friedreich's Ataxia have successfully campaigned for the HSE to fund the drug Skyclarys, following a new financial offer from Biogen. Campaigners express concern that others with rare diseases may need to fight for treatment. The approval brings hope for better management of their condition, though advocates call for changes in the reimbursement system.
    Click here to Read more
    Prev Article
    Households Face Winter Energy Bill Increase
    Next Article
    Apple unveils new Mac mini and Mac Studio

    Related Health Updates:

    Comments (0)

      Leave a Comment